I agree that is a lot of shares to hold onto when they could have sold whenever they wanted to, any time.
Duromist could be a goldmine for NVDL.
A partnership would be a win-win situation for everybody involved.
Another pharma would greatly benefit partnering with NVDL.
Article taken from "The Iron Warrior" from November 28, 2012 :
"Earlier this month, global pharmaceutical company, Pfizer, lost its legal monopoly rights on Viagra in Canada. The Canadian Supreme Court made a unanimous decision on the matter saying that the company should have its patent taken away. On behalf of the court, Justice Louis LeBel wrote “As a matter of policy and sound interpretation, patentees cannot be allowed to ‘game’ the system in this way.” The issue that Pfizer ran into was the fact that the Viagra patent failed to meet the full disclosure requirements set by Canada’s Patent Act. In order to have monopoly rights, the company must disclose the invention and explain how it works. Unfortunately for Pfizer, rather than explaining that the compound sildenafil citrate is the vital component for the treatment of erectile dysfunction, their patent stated that one of the components of Viagra provided the treatment and never actually specified the exact compound."
"So what does this mean for Pfizer? Without the patent rights to Viagra, the company is no longer allowed to have a legal monopoly of the product in Canada. This means that Pfizer has essentially lost all its exclusive control over the supply of Viagra in the country. Does this mean that Canadian men with erectile dysfunction are going be screwed over? No. All this means is that other companies, such as the Israel-based Teva Pharmaceuticals, who actually filed the suit against Pfizer, are allowed to market their versions of Viagra now, rather than after the expiry of Pfizer’s patent which was due in 2014. Analysts believe that this will cause Pfizer to lose all of its $80 million dollar revenue it makes from Canada alone. This is because the generic versions of Viagra, being produced by companies like Teva Pharmaceuticals, are predicted to be much cheaper. Fortunately for the company, though this is a hefty profit loss, it is only a small amount from the $2 billion it makes globally from Viagra alone."
(((((...Not a word from Ratoff about how this affects the potential marketing and
future revenue from the drug "Duromist"......))))))
Everybody here should google the word "Duromist" and learn about what it is and its potential.
From a news report in November 2012, less than 3 months ago:
Generic drugs firms may start producing versions of Viagra in Canada after a court ruled Pfizer's patent was invalid.
The Supreme Court upheld an appeal by Israel's Teva Pharmaceutical that Pfizer's original patent application was incomplete.
Pfizer has successfully defended patent lawsuits by Teva against its erectile dysfunction drug in other countries.
Pfizer said it was "disappointed" by the court's judgement.
The Supreme Court's ruling was a unanimous 7-0. The court said Pfizer had withheld disclosure of certain information about the drug.
Justice Louis LeBel wrote on behalf of the court: "As a matter of policy and sound interpretation, patentees cannot be allowed to 'game' the system in this way."
Pfizer has won patent lawsuits filed by Teva in the US, Spain and New Zealand.
Pfizer said in a statement: "In its decision, the Court determined that the Viagra patent failed to meet certain written disclosure requirements under the Patent Act. Pfizer expects to face generic competition in Canada shortly.
"Pfizer is disappointed with the Court's ruling and will continue to vigorously defend against challenges to its intellectual property. Patents provide a vital incentive for biopharmaceutical companies to invest in new and life-saving medicines that benefit millions of patients worldwide."
Viagra has gone, or is about to go, off-patent in several European countries. The timing depends on when Pfizer originally filed a patent in a country. In Canada, the patent was due to expire in 2014.
Who are all of scooby's "enemies" other than you?
What do you mean by "enemies"?
You sound like a real psycho.
Is "scooby" a threat to you?
Should we "all" be "afraid" of that "scooby" person?
Tallicat has to dig up old postings from 9 months ago about "scooby".
Tallicat is totally obsessed with "Scooby", I wonder why.
Zolpimist should be generating more revenue right now.
Zolpimist is both very safe and very effective.
Zolpimist is NOT promoted or advertised, if it is then tell us where.
More medical insurance companies are now covering the costs for patients using Zolpimist
so that is a great thing.
Zolpimist is comparable to Ambien which is taken in the pill form so it should be generating an equal oreven higher revenue stream than the Ambien pill does.
7 billion dollars per year in sleep aids if that figure is correct is a huge market potential for many millions of dollars in revenue.
Robin, you fail to address the fact that HITK does absolutely NOTHING to promote Zolpimist.
No advertising, no pharmaceutical reps, no promotion of any kind. Whose fault is that? That is only HITK's fault. You talk about a 20 million dollar figure to promote Zolpimist. Nobody else here mentioned that figure. Zolpimist is comparable to Ambien pills so why would it not be promoted as being equal to or in some ways even better than Ambien taken in a pill form? If HITK made an honest effort to promote Zolpimist then I and other people would not even be posting any messages here about it.
Robin, you make many assumptions about why Zolpimist is not being promoted or advertised and you also make many assumptions of why people post messages here about Zolpimist. You happened to be wrong on both counts.
You as a HITK shareholder should NOT try to dismiss any postings about Zolpimist in the way you do because it reflects poorly on you not the other people posting messages here.
By the way Robin, over the past 6-8 months Zolpimist has been added to many more medical insurance companies so patients are being covered for using it so that should be looked at as a very positive thing that HITK should be taking advantage of, so far they have done NOTHING and that is a fact.
Why does any message about zoplimist bother you so much?
Zolpimist should be selling as well or close to what Ambien sales are.
That would mean a lot more revenue for this company.
The fact that it is not selling as it should be something you should want to know why.
Zolpimist is safe, it is very effective, it is being covered by many insurance companies, etc.
You should be asking what the problem is with spending money promoting Zolpimist instead
of trying to censor other people here who ask perfectly logical and very legitimate questions about Zolpimist.
Zolpimist should be promoted better.
No advertising of it and no promotion of it at all so it is a wonder anybody even uses it.
It is a positive thing that Zolpimist is getting more insurance coverage from many more insurance companies.
61 million shares owned by 5% holders, Rechon deal, Confidential SEC Treatment Filing, Duromist, many patents, 2 already approved drugs with revenue streams, etc.
That is good to know.
Less than 3 million dollar market cap here.
I agree same thing can happen with NVDL.
NLTX was 3 cents just a few weeks ago now it is 17 cents.
AMBS was 1 penny a few months ago and now it is 9 cents so that is a 900% gain.
I agree that NVDL is very undervalued now.
Check out the stock HEB and how many lawsuits have been filed against that stock.
There are several other stocks right now with numerous lawsuits filed by their shareholders.
CTIC last year had about 73 class action lawsuits.
Why is this a publicly traded company stock if nothing is ever done to help increase the shareholder equity here?
12 months ago to today nothing, absolutely nothing changed here.
300 thousand dollars per year?
For doing what exactly on a day to day basis?
I guess that is a good sign because why declare bankruptcy when you are getting
a 300 thousand dollar per year salary? Maybe we can all say now that bankruptcy is off the table?
I thought this company had no money 14 months ago so how is it still in business?
So 6 months from now or a year from now we will be saying the same exact thing?
The only "nutjobs" here on this message board are toppedout2000 and his very good friend tallicat.
That total nutjob toppedout likes to post how there was a "huge buy" here or a "huge sell" here when somebody sells only 200 dollars worth of shares. He does that every day.
Sell your shares now toppeyjerk, of course you do not want to, why?
"Oral sprays may work faster than tablets and "eliminate the requirement for water or for the need to swallow, potentially improving patient convenience and adherence," and that Zolpimist is "bioequivalent" to Ambien tablets."
"Because Zolpimist works rapidly, patients should take it "immediately before bedtime and be prepared to get a full night's sleep (7-8 hours)," states NovaDel's news release.
In my opinion and in reality Zolpimist should have a higher revenue stream right now based on it being as good or even better than Ambien taken in a pill form.
There is no logical reason why Zolpimist can't get at least 75% of the market revenue potential that the pill form of Ambien has right now.
How about Duromist?
Why no talk about Duromist now?
Same concept of a spray instead of pill.
Last year there were many more medical insurance companies starting to cover the cost for patients using Zolpimist.
Is price the only determining factor in why people choose Ambien over Zolpimist?
If so what are the differences in cost of Ambien over Zolpimist?
How about Zolpimist getting 75% of the market that Ambien has?
You admit that Zolpimist might even be a better drug than Ambien.
If more insurance companies are starting to cover the cost of Zolpimist as they are doing then that should be looked at as a positive thing.
There should be an aggressive campaign to promote Zolpimist otherwise if that does not happen nothing will ever change here in my opinion. I
It does not matter how great and effective Zolpimist is if it is not promoted or advertised or if there are no pharmaceutical reps going to doctors offices telling doctors about its safety and effectiveness.
What makes anybody think that things will change for the better when nothing has happened for years? Last year at this time we were hoping for this or that and nothing good happened.
Why can't Zolpimist reach the same market potential in terms of revenue as Ambien?